Labeled for this condition
Medicines for opioid use disorder
4 medicines have an FDA label indicated for opioid use disorder; 4 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for opioid use disorder?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Buprenorphine | Belbuca, Brixadi, Butrans | 27 labelers | $0.277 per tablet 2 mg tablet sl | No | No current entry | 12 |
| Buprenorphine and naloxone | Zubsolv, Suboxone | 26 labelers | $0.521 per tablet 2-0.5 mg sl tablet | No | No current entry | 2 |
| Methadone | Diskets | 18 labelers | $0.177 per tablet 10 mg tablet | Yes | No current entry | 4 |
| Naltrexone | Vivitrol | 21 labelers | $1.14 per tablet 50 mg tablet | No | No current entry | 5 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price